Smirnova et al. suggested that SERPINE2 is required in the extracellular milieu of tumors where it acts in multiple ways to regulate tumor matrix deposition, thereby controlling tumor cell dissemination in breast cancer (Smirnova et al., 2016). This evidence concerns the gene SERPINE2 and breast carcinoma.